Pipeline Watch

Pipeline Watch: Four Approvals And Five Phase III Readouts

Pipeline Watch: Four Approvals And Five Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: Eight Approvals And 11 Phase III Readouts

Pipeline Watch: Eight Approvals And 11 Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: 33 Approvals And 19 Phase III Readouts

Pipeline Watch: 33 Approvals And 19 Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: Fourteen Approvals And Forty-Four Phase III Readouts

Pipeline Watch: Fourteen Approvals And Forty-Four Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.


Pipeline Watch: Four Approvals And 32 Phase III Readouts

Pipeline Watch: Four Approvals And 32 Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: Seven Approvals And 13 Phase III Readouts

Pipeline Watch: Seven Approvals And 13 Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: 23 Approvals And Three Phase III Readouts

Pipeline Watch: 23 Approvals And Three Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: 13 Approvals And Two Phase III Readouts

Pipeline Watch: 13 Approvals And Two Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.


Pipeline Watch: 23 Approvals And Three Phase III Readouts

Pipeline Watch: 23 Approvals And Three Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: 11 Approvals And Seven Phase III Readouts

Pipeline Watch: 11 Approvals And Seven Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: 16 Approvals And 16 Phase III Readouts

Pipeline Watch: 16 Approvals And 16 Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: Eight Approvals and Eight Phase III Updates

Pipeline Watch: Eight Approvals and Eight Phase III Updates

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.


Pipeline Watch: 10 Phase III Updates Plus Voquezna And Other Approvals

Pipeline Watch: 10 Phase III Updates Plus Voquezna And Other Approvals

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: 11 Approvals And Two Phase III Readouts

Pipeline Watch: 11 Approvals And Two Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: Nine Approvals And Five Phase III Readouts

Pipeline Watch: Nine Approvals And Five Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: 23 Approvals And 14 Phase III Readouts

Pipeline Watch: 23 Approvals And 14 Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.


Pipeline Watch: 12 Approvals And 18 Phase III Readouts

Pipeline Watch: 12 Approvals And 18 Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: 8 Approvals and 15 Phase III Updates

Pipeline Watch: 8 Approvals and 15 Phase III Updates

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: Respiratory Syncytial Virus Vaccine approved in the US As ASCO Dominates Clinical Trial Readouts

Pipeline Watch: Respiratory Syncytial Virus Vaccine approved in the US As ASCO Dominates Clinical Trial Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch: 10 Approvals And 23 Phase III Readouts

Pipeline Watch: 10 Approvals And 23 Phase III Readouts

 
• By 

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.